HIF1A and familial pancreatic carcinoma: Our results show that this compound decreased pancreatic cancer cell viability (Fig. 5A) and HIF-1α transcriptional activity (Fig. 5B), while having almost no effect on HIF-1α transcription levels (Supplementary Figure 3).